Renaissance Technologies LLC Has $11.01 Million Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Renaissance Technologies LLC raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 117.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 838,800 shares of the company's stock after buying an additional 453,000 shares during the period. Renaissance Technologies LLC owned approximately 0.98% of Pediatrix Medical Group worth $11,005,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp grew its stake in shares of Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after purchasing an additional 50,597 shares during the last quarter. Nordea Investment Management AB boosted its holdings in Pediatrix Medical Group by 51.6% during the fourth quarter. Nordea Investment Management AB now owns 263,633 shares of the company's stock worth $3,504,000 after buying an additional 89,739 shares in the last quarter. Barclays PLC grew its position in Pediatrix Medical Group by 302.9% in the third quarter. Barclays PLC now owns 142,087 shares of the company's stock worth $1,646,000 after buying an additional 106,817 shares during the last quarter. Franklin Resources Inc. bought a new position in shares of Pediatrix Medical Group in the third quarter valued at $598,000. Finally, Principal Financial Group Inc. lifted its position in shares of Pediatrix Medical Group by 14.1% during the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company's stock valued at $5,953,000 after acquiring an additional 63,581 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Up 1.2 %

Shares of MD stock traded up $0.14 during trading on Tuesday, hitting $12.14. 495,602 shares of the company were exchanged, compared to its average volume of 840,526. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -10.12, a P/E/G ratio of 1.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The business's 50-day simple moving average is $14.15 and its 200 day simple moving average is $13.97. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on MD. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Finally, Truist Financial reduced their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Pediatrix Medical Group currently has an average rating of "Hold" and an average price target of $16.75.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.